While new cancer diagnoses have decreased overall since the 1990s, increases in obesity-related cancers are likely slowing this progress, according to the CDC. About two thirds of U.S. adults and ...

Sometimes life can be a precarious balancing act. This balance can be disrupted in any number of ways – including the loss of a job or a divorce or a cancer diagnosis. Traumas like this can lead to ...

Kamath and colleagues from Northwestern University’s Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center analyzed nonprofit cancer organizations with more than $5 million in ...

Cancer vaccines are not a new idea, but they fell out of favor after disappointing results in early studies. Now, a better understanding of how cancer develops and how the immune system responds to it ...

President Biden today accelerated the federal Cancer Moonshot program he launched in 2016 while serving as vice president in the Obama administration. “Today, I’m here to announce our plan to ...

Comparing the two data sets, the researchers found that oropharyngeal cancer risk was positively correlated with a younger age at the time of first oral sex, having oral contact the first time they ...

I found an oncologist at the Mayo Clinic [in Rochester, Minnesota] who specializes in CLL. Initial blood tests suggested a less than 20% chance that I would need treatment in the next five years and ...

Don’t believe it? Jamaican music icon Bob Marley was just 36 when he died of an aggressive form of melanoma (acral lentiginous melanoma) known for primarily affecting people of color. What’s more, ...

What are the risk factors for prostate cancer? The major risk factors for prostate cancer are genetics and family history. Studies looking at the link between prostate cancer and a diet high in red ...

In the AMC-113 study, Stefan Barta, MD, of the Abramson Cancer Center at the University of Pennsylvania, and colleagues analyzed reports from more than a dozen U.S. clinical centers on people with HIV ...

Jemperli made headlines at the 2022 American Society of Clinical Oncology annual meeting when Cercek reported that all 12 patients with locally advanced rectal cancer who completed six months of ...

All study participants with mismatch repair deficient (dMMR) rectal cancer achieved a clinical complete response when treated with the checkpoint inhibitor Jemperli (dostarlimab), according to a ...